IMRX

Immuneering Corp - Class A

NASDAQ · Biotechnology

$4.93

+0.41 (+9.07%)

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

12 analysts

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -28.2% upside

Low Target $2.50

Average Target $3.54

High Target $3.55

Current Price $4.93

Current
$4.93

Target
$3.54

$2.50 $3.54 avg $3.55